We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Legend Biotech
LEGN
$4.01B
| $1.48M | ﹤0.01% |
21,995
+7,530
| +52% | +$523K |
|
2002
Ultrapar
UGP
$6.54B
| $1.47M | ﹤0.01% |
400,982
+660
| +0.2% | +$2.52K |
|
2003
Movado Group
MOV
$841M
| $1.46M | ﹤0.01% |
53,355
-10,672
| -17% | -$290K |
|
|
NKLA
2004
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.46M | ﹤0.01% |
30,943
+1,598
| +5% | +$83.2K |
|
|
THR
2005
DELISTED
Thermon Group Holdings
THR
| $1.45M | ﹤0.01% |
52,917
+1,768
| +3% | +$47.5K |
|
2006
Consensus Cloud Solutions
CCSI
$647M
| $1.45M | ﹤0.01% |
57,612
+771
| +1% | +$23.2K |
|
2007
iShares MSCI France ETF
EWQ
$335M
| $1.45M | ﹤0.01% |
40,740
| – | – |
|
2008
Viking Therapeutics
VKTX
$4B
| $1.45M | ﹤0.01% |
130,888
+3,059
| +2% | +$43.8K |
|
|
PYCR
2009
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $1.44M | ﹤0.01% |
63,031
-2,032
| -3% | -$48.4K |
|
2010
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.44M | ﹤0.01% |
98,969
+671
| +0.7% | +$12.7K |
|
|
WCN
2011
Waste Connections
WCN
$42B
| $1.42M | ﹤0.01% |
10,594
+56
| +0.5% | +$7.83K |
|
|
ZUO
2012
DELISTED
Zuora, Inc.
ZUO
| $1.42M | ﹤0.01% |
172,236
+6,869
| +4% | +$67.7K |
|
2013
OraSure Technologies
OSUR
$279M
| $1.42M | ﹤0.01% |
239,324
-2,766
| -1% | -$15.5K |
|
2014
Newmark Group
NMRK
$2.63B
| $1.42M | ﹤0.01% |
220,252
-50,285
| -19% | -$348K |
|
2015
Phreesia
PHR
$773M
| $1.41M | ﹤0.01% |
75,704
-1,229
| -2% | -$33.1K |
|
2016
Select Water Solutions
WTTR
$2.61B
| $1.41M | ﹤0.01% |
177,006
+3,320
| +2% | +$27.3K |
|
2017
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.4M | ﹤0.01% |
180,680
+1,554
| +0.9% | +$15.2K |
|
2018
Invesco Mortgage Capital
IVR
$805M
| $1.4M | ﹤0.01% |
139,901
+8,032
| +6% | +$88.8K |
|
2019
CEVA Inc
CEVA
$1.08B
| $1.4M | ﹤0.01% |
72,000
+735
| +1% | +$17.1K |
|
2020
United Fire Group
UFCS
$1.4B
| $1.39M | ﹤0.01% |
70,622
-1,507
| -2% | -$31.5K |
|
2021
Flex
FLEX
$44.8B
| $1.39M | ﹤0.01% |
68,586
+12,492
| +22% | +$253K |
|
2022
ADT
ADT
$5.58B
| $1.39M | ﹤0.01% |
232,059
-5,063
| -2% | -$31.6K |
|
|
CDMO
2023
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.39M | ﹤0.01% |
147,136
-332
| -0.2% | -$4K |
|
2024
QuinStreet
QNST
$1.21B
| $1.39M | ﹤0.01% |
154,580
+1,389
| +0.9% | +$12.9K |
|
2025
Protagonist Therapeutics
PTGX
$9.44B
| $1.38M | ﹤0.01% |
82,809
+4,898
| +6% | +$95K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.